Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer. Discover more about us below...
Committed to tackling the World Health Organisation's priority diseases - HIV/AIDS, Tuberculosis and malaria.
5%: GSK's share of the world pharmaceuticals market.
10th anniversary of our programme to help eliminate lymphatic filariasis celebrated in 2008.
15 years supporting Positive action, a charity supporting communities with HIV/AIDS.
Late stage programmes in our product pipeline (in 2010).
Our vaccines are included in immunisation campaigns in 182 countries worldwide.
The year GSK was created through the merger of GlaxoWellcome and Smith Kline Beecham.
In 2009 we launched ViiV Healthcare with Pfizer to deliver advances in treatment and care for people living in HIV
Our vision is for our value chain to be carbon neutral by 2050
About 13,000 people work in our research teams discovering new medicines.
Each year, our manufacturing teams make 28,000 different presentations of our products including tablets, creams, inhalers and injections.
We employ more than 97,000 people in over 100 countries, with more than a third of these in emerging markets.